Literature DB >> 27420953

Borax-induced apoptosis in HepG2 cells involves p53, Bcl-2, and Bax.

Y Wei1, F J Yuan2, W B Zhou2, L Wu2, L Chen1, J J Wang1, Y S Zhang2.   

Abstract

Borax, a boron compound and a salt of boric acid, is known to inhibit the growth of tumor cells. HepG2 cells have been shown to be clearly susceptible to the anti-proliferative effects of borax. However, the specific mechanisms regulating this effect are poorly understood. This study aimed to investigate the pathways underlying the growth inhibition induced by borax in HepG2 cells. The effects of borax on HepG2 cell viability were characterized using MTT. Apoptosis was also verified by annexin V/propidium iodide staining. JC-1 dye and western blotting techniques were used to measure mitochondrial membrane potential and p53, Bax, and Bcl-2 protein expression, respectively. Relevant mRNA levels were measured by qRT-PCR. Borax inhibited the proliferation of HepG2 cells in a time- and dose-dependent manner in vitro. The apoptotic process triggered by borax involved the upregulation of p53 and Bax and the downregulation of Bcl-2, which was confirmed by a change in the mitochondrial membrane potential. These results elucidate a borax-induced apoptotic pathway in HepG2 cells that involves the upregulation of p53 and Bax and the downregulation of Bcl-2.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27420953     DOI: 10.4238/gmr.15028300

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line.

Authors:  Ömer Faruk Kırlangıç; Ecem Kaya-Sezginer; Sema Ören; Serap Gür; Özlem Yavuz; Taner Özgürtaş
Journal:  Turk J Pharm Sci       Date:  2022-08-31

2.  Gene expression alterations of human liver cancer cells following borax exposure.

Authors:  Lun Wu; Ying Wei; Wen-Bo Zhou; You-Shun Zhang; Qin-Hua Chen; Ming-Xing Liu; Zheng-Peng Zhu; Jiao Zhou; Li-Hua Yang; Hong-Mei Wang; Guang-Min Wei; Sheng Wang; Zhi-Gang Tang
Journal:  Oncol Rep       Date:  2019-05-23       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.